STAT Plus: Gilead CEO parries with congressional Democrats over an HIV prevention pill
PAUL SAKUMA/AP
The three-hour session was punctuated by bipartisan sparring that addressed the larger issue of patients versus profits as much as the Gilead pill.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario